Open Access

Erratum to Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

  • Ondrej Slaby1, 3Email author,
  • Jana Jancovicova4,
  • Radek Lakomy1,
  • Marek Svoboda1,
  • Alexandr Poprach1,
  • Pavel Fabian2,
  • Leos Kren5,
  • Jaroslav Michalek3 and
  • Rostislav Vyzula1
Journal of Experimental & Clinical Cancer Research201029:105

DOI: 10.1186/1756-9966-29-105

Received: 30 July 2010

Accepted: 6 August 2010

Published: 6 August 2010

The original article was published in Journal of Experimental & Clinical Cancer Research 2010 29:90

Correction

After the publication of this research article [1], the authors noticed an error with Figure 1. Graph D which should have indicated miR-106b expression levels in renal parenchyma (RP) and renal cell carcinomas (RCC), was mistakenly displayed as a duplicate of Graph C. The corrected Figure 1 is provided here.
https://static-content.springer.com/image/art%3A10.1186%2F1756-9966-29-105/MediaObjects/13046_2010_Article_352_Fig1_HTML.jpg

Figure 1

Notes

Declarations

Authors’ Affiliations

(1)
Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care
(2)
Masaryk Memorial Cancer Institute, Department of Oncological and Experimental Pathology
(3)
Babak Research Institute, University Cell Immunotherapy Center
(4)
Masaryk University, Faculty of Science, Department of Biochemistry
(5)
University Hospital Brno, Department of Pathology, Faculty of Medicine, Masaryk University

References

  1. Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. Journal of Experimental & Clinical Cancer Research. 2010, 29: 90-10.1186/1756-9966-29-90.View ArticleGoogle Scholar

Copyright

© Slaby et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement